To Evaluate Safety and Immunogenicity of a Prophylactic Plasmid DNA

NCT06436911 · clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
COMPLETED
Status
46
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Entos Pharmaceuticals Inc.

Collaborators